Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Recipharm Acquires Cobra Biomanufacturing | Contract Pharma

What are you searching for?

Sign in
Breaking News

Recipharm Acquires Cobra Biomanufacturing

Recipharm AB has acquired Cobra Biomanufacturing and combined it with its existing biologics business in Sweden.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Recipharm AB has acquired Cobra Biomanufacturing and combined it with its existing biologics business in Sweden. The integrated companies will be called RecipharmCobra Biologics and will operate as Recipharm’s specialist biologics division.

The acquisition creates a biological service offering that includes cell line development, analytical and process development and GMP production of recombinant proteins, DNA, viruses and cell products for Phase I – III trials, as well as fill-finish and formulation capabilities.

RecipharmCobra Biologics will have cGMP-approved production facilities in Keele and Oxford, UK and Södertälje, Sweden, and holds IP and licenses in expression technologies, including ORT-VAC and UCOE.

Simon Saxby, former chief executive officer of Cobra Biomanufacturing, will head up RecipharmCobra Biologics, serving as vice president, Biologics.

Thomas Eldered, chief executive officer of Recipharm AB, commented, “Integrating the experience of Cobra Biomanufacturing’s staff, expertise and established services with our own previous offering has, we believe, created a much stronger force in the industry’s biologics outsourcing sector. Indeed, in addition to antibodies and rProteins, our integrated company competitively offers both process development and cGMP manufacturing services for viruses, DNA and cells.”


Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics